Sign In

A subscription to JoVE is required to view this content. Sign in or start your free trial.

In This Article

  • Summary
  • Abstract
  • Introduction
  • Protocol
  • Representative Results
  • Discussion
  • Disclosures
  • Acknowledgements
  • Materials
  • References
  • Reprints and Permissions

Summary

This protocol describes how to use the MEDUSA analytical method to quantify the death regulatory effect of each gene knockout. It includes instructions on determining experimental conditions that optimize sensitivity and a step-by-step tutorial on performing the analysis.

Abstract

Systematic screening of gain- or loss-of-function genetic perturbations can be used to characterize the genetic dependencies and mechanisms of regulation for essentially any cellular process of interest. These experiments typically involve profiling from a pool of single gene perturbations and how each genetic perturbation affects the relative cell fitness. When applied in the context of drug efficacy studies, often called chemo-genetic profiling, these methods should be effective at identifying drug mechanisms of action. Unfortunately, fitness-based chemo-genetic profiling studies are ineffective at identifying all components of a drug response. For instance, these studies generally fail to identify which genes regulate drug-induced cell death. Several issues contribute to obscuring death regulation in fitness-based screens, including the confounding effects of proliferation rate variation, variation in the drug-induced coordination between growth and death, and, in some cases, the inability to separate DNA from live and dead cells. MEDUSA is an analytical method for identifying death-regulatory genes in conventional chemo-genetic profiling data. It works by using computational simulations to estimate the growth and death rates that created an observed fitness profile rather than scoring fitness itself. Effective use of the method depends on optimal tittering of experimental conditions, including the drug dose, starting population size, and length of the assay. This manuscript will describe how to set up a chemo-genetic profiling study for MEDUSA-based analysis, and we will demonstrate how to use the method to quantify death rates in chemo-genetic profiling data.

Introduction

In chemo-genetic profiling, systematic genetic perturbations are used to understand the contribution of each gene to a given drug response1,2,3. These experiments are valuable and can reveal important insights about drug responses, including the drug's binding target and mechanisms of drug influx/efflux. However, because these experiments are typically performed in a pooled manner that evaluates all genes simultaneously, generating mechanistic insights from chemo-genetic profiling data can be challenging.

The control mechanisms and genetic depe....

Protocol

1. Optimization of the drug dose to induce cell death

NOTE: The protocol below is for optimizing one combination of cell line, drug, and dose using the FLICK assay7,8. The example data for this protocol describes the optimization and screening of 5 μM etoposide in U2OS cells, but the same optimization steps could be applied to any other desired combination of cell line and drug/dose. This protocol does not require the collection or analysis of dead cells. This protocol can be used for suspension cultures, provided that dead cells are removed. For suspension cultu....

Representative Results

Using this protocol, we explored the genetic dependencies of etoposide-induced death in U2OS cells. Etoposide is a commonly used DNA-damaging chemotherapy15. This chemo-genetic profiling experiment was performed using the GeCKOv2 library16 in Cas9 expressing U2OS cells5. In these types of experiments, gene function is typically inferred from the relative abundance of a given knockout clone when comparing drug-treated versus untreated populations (

Discussion

In this protocol, we describe the use of the MEDUSA analytical method for quantifying chemo-genetic profiling data to score how genetic perturbations alter drug-induced growth and death rates. Because the primary output of a chemo-genetic profiling experiment is related to population size, not rates, the underlying rates are inferred using simulations. Thus, the critical steps in the method are the accurate experimental parameterization of drug response kinetics, which includes the untreated cell proliferation rate, the .......

Disclosures

The authors have no conflicts of interest to disclose.

Acknowledgements

We thank all members of the Lee Lab, past and present, for their contributions to our lab's point of view on evaluating drug responses. This work was supported by funding MJL and MEH from the National Institutes of Health (U01CA265709, R21CA294000, and R35GM152194 to MJL, and F31CA268847 to MEH), the funding MJL from the Jayne Koskinas Ted Giovanis Foundation.

....

Materials

NameCompanyCatalog NumberComments
100mm Fisherbrand TC DishesFisher ScientificFB012924For growing cells and optimizing population size
150mm Fisherbrand TC DishesFisher ScientificFB012925For growing cells and optimizing population size
DESeq2R Packagev1.44.0For calculating fold-change
DMEMCorning10017CVFor seeding and drugging cells
DMSOFisher ScientificMT-25950CQCFor seeding and drugging cells
Fisherbrand 96-Well, Cell Culture-Treated, U-Shaped-Bottom MicroplateFisher ScientificFB012932For seeding and drugging cells (pin plate)
Greiner Bio-One CELLSTAR μClear 96-well, Cell Culture-Treated, Flat-Bottom MicroplateGreiner655090For seeding and drugging cells
MATLABMathworks R2024aFor performing FLICK, GRADE, and MEDUSA
Microplate fluorescence readerTecanSparkFor dead cell measurements
Sytox GreenThermo Fisher ScientificS7020For dead cell measurements
TKOV3 CRISPR libraryAddgene125517For performing CRISPR screen
Triton-X 100Thermo Fisher ScientificJ66624-APFor permeabilizing cells
Trypan blue CorningMT25900CIFor measure live/dead cells

References

  1. Przybyla, L., Gilbert, L. A. A new era in functional genomics screens. Nat Rev Genet. 23 (2), 89-103 (2021).
  2. Colic, M., Hart, T. Chemogenetic interactions in human cancer cells. Comput Struct Biotechnol J. 17, 1318-13....

Reprints and Permissions

Request permission to reuse the text or figures of this JoVE article

Request Permission

This article has been published

Video Coming Soon

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2025 MyJoVE Corporation. All rights reserved